About Formation Bio
Formation Bio is a company based in New York (United States) founded in 2016 by Benjamine Liu and Linhao Zhang. Formation Bio has raised $608 million across 4 funding rounds from investors including Sanofi, Spark Capital and ArrowMark Partners. Formation Bio offers products and services including Drug Development Platform. Formation Bio operates in a competitive market with competitors including Incyte, LEO Pharma, Flexion Therapeutics, Owkin and AbSci, among others.
- Headquarter New York, United States
- Founders Benjamine Liu, Linhao Zhang
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$608 M (USD)
in 4 rounds
-
Latest Funding Round
$372 M (USD), Series D
May 21, 2024
-
Investors
Sanofi
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Formation Bio
Formation Bio offers a comprehensive portfolio of products and services, including Drug Development Platform.
Accelerates drug development using AI for efficient clinical trials
People of Formation Bio
Unlock access to complete
Unlock access to complete
Software Development Team
9 people
Human Resources and Administration
6 people
Product Management Team
6 people
Advisor Team
6 people
Leadership Team
5 people
Finance and Accounting
4 people
Sales and Marketing
4 people
Data Analysis and Operations Team
3 people
Unlock access to complete
Funding Insights of Formation Bio
Formation Bio has successfully raised a total of $608M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $372 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Formation Bio
Formation Bio has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Sanofi, Spark Capital and ArrowMark Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
Philanthropic assets are managed by Willett Advisors LLC.
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked |
Investor details for Formation Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Formation Bio
Investment portfolio details for Formation Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Formation Bio
Detailed financials for Formation Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Formation Bio Comparisons
Peer comparison for Formation Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Formation Bio
Formation Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, LEO Pharma, Flexion Therapeutics, Owkin and AbSci, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Developer of drugs for treating dermatology diseases
|
|
| Locked | Locked | Locked |
Developer of therapies for the treatment of musculoskeletal disorders
|
|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
Detailed competitors of Formation Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Formation Bio
Complete news archive for Formation Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Formation Bio
Formation Bio was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Formation Bio is headquartered in New York, United States. It is registered at New York, New York, United States.
Benjamine Liu is the current CEO of Formation Bio. They have also founded this company.
Formation Bio is a funded company, having raised a total of $608M across 4 funding rounds to date.
AI-powered drug discovery platform for various diseases. The company leverages technology such as LLMs and the modern data stack in novel ways to efficiently design and operate clinical development in Atopic Dermatitis, Chronic Hand Eczema, and Knee Osteoarthritis.
Formation Bio's top competitors include Owkin, Flexion Therapeutics and LEO Pharma.
Formation Bio offers Drug Development Platform.
Formation Bio has 13 investors. Key investors include Sanofi, Spark Capital, ArrowMark Partners, Andreessen Horowitz, and Willett Advisors.